Seizure recurrence at 5 years after randomisation · people with neurocysticercosis
Albendazole showed no clear difference in seizure recurrence ‐ all participants compared with placebo or no anthelmintics (low certainty).
1 finding from 1 review
Seizure recurrence ‐ participants with a single cyst · people with neurocysticercosis
Albendazole probably leads to lower seizure recurrence ‐ participants with a single cyst compared with placebo or no anthelmintics (moderate certainty).
1 finding from 1 review
Seizure recurrence ‐ participants with multiple (> 1) cysts · people with neurocysticercosis
It is very uncertain whether albendazole changes seizure recurrence ‐ participants with multiple (> 1) cysts compared with placebo or no anthelmintics (very low certainty).
1 finding from 1 review
Complete radiological clearance of lesions · people with neurocysticercosis
Albendazole probably leads to higher complete radiological clearance of lesions compared with placebo or no anthelmintics (moderate certainty).
1 finding from 1 review
Evolution of cysts · people with neurocysticercosis
Albendazole probably leads to higher evolution of cysts compared with placebo or no anthelmintics (moderate certainty).
1 finding from 1 review
Parasitological cure · children and adults
Albendazole 400 mg single dose showed no clear difference in parasitological cure compared with albendazole 400 mg multiple doses (high certainty).
1 finding from 1 review
Faecal egg count · children and adults
1 finding from 1 review
Adverse events · children and adults
1 finding from 1 review
Parasitological cure · children and adults
Albendazole single dose showed no clear difference in parasitological cure compared with ivermectin single dose cure rate (moderate certainty).
1 finding from 1 review
Faecal egg count · children and adults
1 finding from 1 review
Adverse outcomes · children and adults
1 finding from 1 review
Parasitological cure · children and adults
Albendazole 400 mg single dose showed no clear difference in parasitological cure compared with mebendazole 500 mg single dose (high certainty).
1 finding from 1 review
Faecal egg count · children and adults
1 finding from 1 review
Adverse events · children and adults
1 finding from 1 review
Intervention not reported
Microfilaraemia (mf) prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in microfilaraemia (mf) prevalence (high certainty).
1 finding from 1 review
Intervention not reported
Mf density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Antigenaemia prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in antigenaemia prevalence (high certainty).
1 finding from 1 review
Intervention not reported
Antigen density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Adult worm prevalence detected by ultrasound ‐ not measured · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in adverse events (moderate certainty).
1 finding from 1 review